Tilray Inc. (TLRY)

31.31
NASDAQ : Health Technology
Prev Close 35.12
Day Low/High 30.58 / 35.77
52 Wk Low/High 27.65 / 300.00
Avg Volume 1.46M
Exchange NASDAQ
Shares Outstanding 80.98M
Market Cap 3.43B
EPS -0.80
P/E Ratio N/A
Div & Yield N.A. (N.A)

Get It While You Can… At Your Own Risk

"In this world, if you read the papers, darling You know everybody's fighting ah with each other You got no one you can count on babe Not even your own brother So if someone comes along He gonna give you some love and affection I'd say get it while ...

Jim Cramer: Why Micron May Be Good Value Right Now

Jim Cramer: Why Micron May Be Good Value Right Now

The $5 billion buyback and solid balance sheet could signal this is actually an investible growth stock.

Cannabis-Related Products Could Be Your Dog's Best Friend (And Your Portfolio's)

Cannabis-Related Products Could Be Your Dog's Best Friend (And Your Portfolio's)

Expert says weed-related products for pets could become a $55 billion-a-year business.

Chart of the Day: Tilray Is Worth More Than Goodyear and Xerox Combined

Chart of the Day: Tilray Is Worth More Than Goodyear and Xerox Combined

It also beats Nordstrom and Boston Beer Co.

Reefer Madness Is Spreading Even as Tilray Cools Down

Reefer Madness Is Spreading Even as Tilray Cools Down

Intelgenx Technologies soars 115% on non-binding letter of intent to work with Tilray.

Canopy Growth CEO: Traditional Firms Will See They Must Get Into Legal Cannabis

Canopy Growth CEO: Traditional Firms Will See They Must Get Into Legal Cannabis

The only other option is 'to fearfully wait' for the legal-weed industry to expand.

3D Systems Appears Ready to Break Higher

3D Systems Appears Ready to Break Higher

I'm intrigued by the stock here.

Trading Hot Sectors Like Cannabis Regardless of Valuations

Trading Hot Sectors Like Cannabis Regardless of Valuations

These speculative frenzies all have a number of things in common.

For Patient Longs, Green Organic Could See a Lot More 'Green'

For Patient Longs, Green Organic Could See a Lot More 'Green'

Let's review a couple of charts.

Cannabis Frenzy Continues With New Age Beverages and Corbus Pharmaceuticals

Cannabis Frenzy Continues With New Age Beverages and Corbus Pharmaceuticals

Aggressive traders are beating the bushes looking for the next big mover.

Canopy Growth CEO Sees Dot-Com-Like Bust for Many Weed Stocks

Canopy Growth CEO Sees Dot-Com-Like Bust for Many Weed Stocks

'There's too much hype too soon,' Canopy Growth chief Bruce Linton says.

Did You Ever Imagine a Stock Like Tilray?

Did You Ever Imagine a Stock Like Tilray?

Let's visit with three charts to see what we can glean about today and tomorrow.

Don't Follow (or Trade/Invest in) the Shiny Object Called Tilray

* Tilray is now a sideshow of classic speculative activity - it will likely end badly * Neither go short nor go long * Ignore TLRY and move on, it's a distraction and you may miss other opportunities Henry: (narrating) "And then there was Jimmy Two ...

Jim Cramer: Reefer Madness

Jim Cramer: Reefer Madness

Tilray's a disruptive company for many industries.

If You Must Trade Tilray, Use This Options Play: Market Recon

If You Must Trade Tilray, Use This Options Play: Market Recon

Covered calls may be the best bet -- or wait for a dip.

Tilray Closes up 38% After Wild Trading Day

Tilray Closes up 38% After Wild Trading Day

Shares were up 94% and down 2.3% in the same session.

Tilray and Other Cannabis Firms Have Even More Catalysts on the Horizon

Tilray and Other Cannabis Firms Have Even More Catalysts on the Horizon

Canadian marijuana legalization and U.S. approval of industrial hemp are coming.

Was Tilray's Wild Day Sign of a Market Top?

Was Tilray's Wild Day Sign of a Market Top?

Tilray provided good entertainment and there were crazy pockets of momentum.

Jim Cramer: The Tilray Short Squeeze

Jim Cramer: The Tilray Short Squeeze

Cannabis companies should be taking advantage of the mania to raise money.

My New Age Beverages Trade Is Killing It (Glad I Didn't Listen to the Bears!)

My New Age Beverages Trade Is Killing It (Glad I Didn't Listen to the Bears!)

Tilray isn't the only cannabis stock soaring these days.

Tilray's Sales Are Irrelevant and Its Charts Don't Matter

Tilray's Sales Are Irrelevant and Its Charts Don't Matter

Don't try to explain the stock's meteoric rise on a fundamental or technical basis, because it defies both.

What, Me, Worry?

"Is there anything at all that can derail this stock market rally?" -- Brian Sullivan, CNBC (today) To me all the ingredients for a market drop are now in place: * Speculative activity is on the rise (materially so in the case of Tilray and others i...

How to Play Tilray With Options

How to Play Tilray With Options

A so-called 'ratio-put spread' looks good here.

Play Tilray Using a 'Ratio-Put Spread'

Play Tilray Using a 'Ratio-Put Spread'

This options trade combines some upside with a chance to buy TLRY at a decent price.

Absolutely Absurd!

This is absolutely absurd and consistent with an increasingly irrational and speculative market: Today Tilray has a market cap of over $20 billion. This compares to Western Digital at $17.5 billion, Hartford Financial at $18 billion, to Kellogg at $...

Red-Hot Tilray Morphs Into Game of Trading Other Traders, Not the Stock

Red-Hot Tilray Morphs Into Game of Trading Other Traders, Not the Stock

At some point Tilray is going to suffer a very ugly drop, but trying to guess when is like trying to time a slot machine.

Tilray Foolishness

"The problem with the world is that fools and fanatics are always so certain of themselves and wiser people so full of doubts." -- Bertrand Russell  The interest rate for a Tilray borrow is now over 264% -- that's annually! Be forewarned.

Tilray Surges Over 50% Wednesday Morning, Punishing Short-Sellers

Tilray Surges Over 50% Wednesday Morning, Punishing Short-Sellers

The cannabis company has gained DEA approval to import a cannabinoid drug into the U.S.

Another Short-Selling Lesson (Part Deux)

* Tilray is now a sideshow of classic speculative activity * Neither go short nor go long TLRY * Ignore TLRY and move on Pot stock Tilray, Inc. is trading at $215/share (+$60 in premarket trading).  The short squeeze is reminiscent of Robert Wilson'...

Cannabis Craziness